APA (7th ed.) Citation

Ruan, X., Huang, D., Lin, X., Fang, Z., Ding, Q., Wu, Y., & Na, R. (2023). Germline mutations in 5' to c.7914 of BRCA2 significantly increase risk of prostate cancer. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Ruan, Xiao-Hao, Da Huang, Xiao-Ling Lin, Zu-Jun Fang, Qiang Ding, Yi-Shuo Wu, and Rong Na. Germline Mutations in 5' to C.7914 of BRCA2 Significantly Increase Risk of Prostate Cancer. Wolters Kluwer Medknow Publications, 2023.

MLA (9th ed.) Citation

Ruan, Xiao-Hao, et al. Germline Mutations in 5' to C.7914 of BRCA2 Significantly Increase Risk of Prostate Cancer. Wolters Kluwer Medknow Publications, 2023.